Lin Y, Berdeja J, Raje N, et al. First-in-human multicenter study of BB2121 anti-BCMA CAR T cell therapy for relapsed/refractory multiple myeloma: updated results. EHA 2017, abstract 142.
Quizartinib plus chemotherapie bij nieuw gediagnosticeerde FLT3-ITD-positieve AML
jul 2023 | Leukemie